Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.3800
+0.02306.44%
Volume:31.75K
Turnover:11.86K
Market Cap:14.84M
PE:-0.18
High:0.3800
Open:0.3600
Low:0.3600
Close:0.3570
Loading ...

Athira Pharma Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
28 Jul

Mizuho Securities Keeps Their Hold Rating on Athira Pharma (ATHA)

TIPRANKS
·
23 Jul

Athena Gold Boosts Visibility with New Marketing Agreements

TIPRANKS
·
04 Jul

Mark Worthington, General Counsel and CCO, Reports Disposal of Athira Pharma Inc. Common Shares

Reuters
·
03 Jul

Athena Gold Closes CAD $166,100 Private Placement to Fund Exploration

TIPRANKS
·
01 Jul

Athena Gold Grants Stock Options to Key Personnel

TIPRANKS
·
13 Jun

Athira Pharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
03 Jun

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105

TIPRANKS
·
13 May

Athira Pharma Reports Reduced Losses and Strategic Focus

TIPRANKS
·
10 May

Athira Pharma Q1 EPS $(0.23) Up From $(0.69) YoY

Benzinga
·
10 May

BRIEF-Athira Pharma Q1 EPS USD -0.23

Reuters
·
10 May

Athira Pharma Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
09 May

ATHA Energy Secures $10 Million for Uranium Exploration

TIPRANKS
·
22 Apr

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained

TIPRANKS
·
03 Mar

Athira Pharma’s 2024 Financial Results and Pipeline Progress

TIPRANKS
·
01 Mar

Athira Pharma (ATHA) Gets a Hold from JMP Securities

TIPRANKS
·
28 Feb

Athira Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate

Benzinga
·
28 Feb

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire
·
28 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
24 Feb